Position of the Y-chromosome at somatic metaphase in patients with chronic myelogenous leukemia (CML)
Verma, R.S.; Thomas, S.; Coleman, M.; Silver, R.T.; Dosik, H.
Experientia 42(4): 440-441
1986
ISSN/ISBN: 0014-4754 PMID: 3456903 Document Number: 279312
A random distribution of the Y-chromosome at somatic metaphase was found in 50 patients with Ph' positive chronic myelogenous leukemia (CML). Thus, it is concluded that the 'positive' of the Y-chromosome at somatic metaphase does not appear to influence the loss from bone marrow cells.
Document emailed within 1 workday
Related Documents
Hecht, F.; Hecht, B.K. 1994: Human somatic cell metaphase chromosome measurements Annales de Genetique 37(1): 44-45Carbonell, F.; Grilli, G. 1981: Cytogenetical changes in Philadelphia chromosome-positive chronic myelogenous leukemia Medicina Clinica 77(10): 420-423
Fukuda, T. 1986: Characterization and differentiation of basophilic precursor cells in Philadelphia chromosome positive chronic myelogenous leukemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(5): 1024-1036
Lin, Y.T.; Lin, D.T.; Jou, S.T.; Lin, K.S.; Lin, K.H. 1997: Allogeneic bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childhood Journal of the Formosan Medical Association 96(5): 320-324
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Dini, G.; Rondelli, R.; Miano, M.; Vossen, J.; Gluckman, E.; Peters, C.; Bordigoni, P.; Locatelli, F.; Miniero, R.; Ljungman, P.; Saarinen, U.; Klingebiel, T.; Ortega, J.; Lanino, E. 1996: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. the EBMT Paediatric Diseases Working Party Bone Marrow Transplantation 18(Suppl 2): 80-85
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Brière, J.; Castro-Malaspina, H.; Tanzer, J.; Bernard, J. 1975: Subacute myelogenous leukemia with Phildelphia chromosome Nouvelle Revue Francaise d'Hematologie 15(4): 407-423
Kantarjian, H.M.; Keating, M.J.; McCredie, K.B.; Walters, R.; Talpaz, M.; Smith, T.L.; Freireich, E.J. 1987: Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia Southern Medical Journal 80(10): 1228-1232
Eaves, A.C.; Eaves, C.J. 1979: Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML) Experimental Hematology 7(Suppl 5): 65-75
Sanada, M. 1984: Abnormal negative feedback control of granulopoiesis in patients with chronic myelogenous leukemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 47(4): 950-957
Kuwao, F.; Takahashi, I. 1993: Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method Leukemia 7(8): 1168-1173
Ruiz-Argüelles, G.J.; Gómez-Almaguer, D.; López-Martínez, B.; Cantú-Rodríguez, O.G.; Jaime-Pérez, Jé.C.; González-Llano, O. 2002: Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia Haematologica 87(8): 894-896
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Opalka, B.; Wandl, U.; Beer, U.; Roggenbuck, U.; Kloke, O.; Niederle, N. 1991: Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy Leukemia 5(6): 452-456
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Martinelli, G.; Testoni, N.; Montefusco, V.; Amabile, M.; Saglio, G.; Ottaviani, E.; Terragna, C.; Bonifazzi, F.; de Vivo, A.; Pane, F.; Rosti, G.; Tura, S. 1998: Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis Haematologica 83(7): 593-601
Usman, M.; Kakepoto, G.N.; Adil, S.N.; Sajid, R.; Arain, S.; Khurshid, M. 2004: Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a tertiary care hospital Jpma. Journal of the Pakistan Medical Association 54(1): 17-20